Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 14, Number 6—June 2008

High Failure Rates of Melarsoprol for Sleeping Sickness, Democratic Republic of Congo

Jo Robays*Comments to Author , Gaspard Nyamowala†‡, Claude Sese†, Victor Betu Ku Mesu Kande†, Pascal Lutumba†§, Wim Van der Veken¶, and Marleen Boelaert*
Author affiliations: *Institute of Tropical Medicine, Antwerp, Belgium; †Programme National de Lutte contre la Trypanosomiase Humaine Africaine, Kinshasa, Democratic Republic of Congo; ‡Medische Missie Samenwerking Organisation, Kinshasa; §University of Kinshasa, Kinshasa; ¶Belgian Technical Cooperation, Kinshasa;

Main Article

Table 2

Characteristics of 959 patients who experienced relapse after treatment 
with melarsoprol, Equateur Nord Province, 2001–2003

Characteristic No. (%)
M 433 (45.2)
526 (54.8)
>1–11mo 1 (0.1)
12–59 mo 13 (1.4)
5–59 y 936 (97.6)
>60 y
9 (0.9)
Stage of disease
First 46 (4.8)
Second 782 (81.5)
131 (13.7)
Parasites found 259 (27.0)

Main Article

Page created: July 09, 2010
Page updated: July 09, 2010
Page reviewed: July 09, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.